Send to

Choose Destination
Genes Chromosomes Cancer. 1992 Jul;5(1):89-90.

Detection of loss of heterozygosity at the human TP53 locus using a dinucleotide repeat polymorphism.

Author information

Department of Biochemistry, Cancer Institute, Tokyo, Japan.


Loss of heterozygosity at the TP53 locus occurs frequently in many types of cancer and requires polymorphic markers for detection. Several polymorphisms at the TP53 locus have been described previously, and polymerase chain reaction (PCR)-based assays have been developed to detect these polymorphisms. However, these polymorphisms have relatively low levels of heterozygosity and are often uninformative. We report here the detection of loss of heterozygosity at the TP53 locus in various human cancers by using a highly informative dinucleotide repeat polymorphism.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center